Company Profiles

driven by the PitchBook Platform

Allena Pharmaceuticals

Description

Developer of non-systemic protein therapeutics designed to treat metabolic diseases. The company's non-systemic protein therapeutics reduce the burden of toxic metabolites such as oxalate and uric acid, as well as deliver therapies that are designed to target a specific metabolic compound in the gut without systemic absorption, enabling patients with complex metabolic conditions to get improved treatment.

2011

Founded

PRIVATE

Status

11-50

Employees

Later Stage VC

Latest Deal Type

$2.67M

Latest Deal Amount

$96M

Total Amount Raised

Description

Developer of non-systemic protein therapeutics designed to treat metabolic diseases. The company's non-systemic protein therapeutics reduce the burden of toxic metabolites such as oxalate and uric acid, as well as deliver therapies that are designed to target a specific metabolic compound in the gut without systemic absorption, enabling patients with complex metabolic conditions to get improved treatment.

Website:

www.allenapharma.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Other Pharmaceuticals and Biotechnology

Primary Office

One Newton Executive Park Suite 202 Newton, MA 02462United States +1 (617) 467-4577
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Allena Pharmaceuticals's full profile, request a free trial.

    Allena Pharmaceuticals Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Allena Pharmaceuticals Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Allena Pharmaceuticals Investors (9)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Bessemer Venture PartnersVenture CapitalMinority000 0000000 0000
    Fidelity Management & ResearchOtherMinority000 0000000 0000
    Frazier Healthcare PartnersGrowth/ExpansionMinority000 0000000 0000
    HBM PartnersInvestment BankMinority000 0000000 0000
    Inbio VenturesVenture CapitalMinority000 0000000 0000
    Bessemer Venture Partners Venture Capital
    Fidelity Management & Research Other
    Frazier Healthcare Partners Growth/Expansion
    HBM Partners Investment Bank
    Inbio Ventures Venture Capital

    Allena Pharmaceuticals Executive Team (6)

    NameTitleBoard
    Seat
    Contact
    Info
    Louis Brenner MDChief Operating Officer & President
    Edward WholihanChief Financial Officer
    Annamaria Kausz MDVice President, Clinical Development
    Hugh WightVice President, Technical Operations
    Robert GallottoCo-Founder
    Louis Brenner MD Chief Operating Officer & President
    Edward Wholihan Chief Financial Officer
    Annamaria Kausz MD Vice President, Clinical Development
    Hugh Wight Vice President, Technical Operations
    Robert Gallotto Co-Founder

    Allena Pharmaceuticals Board Members (7)

    NameRepresentingRoleSinceContact
    Info
    Alexey Margolin Ph.DAllena PharmaceuticalsCo-Founder, Chief Executive Officer & Board Member000 0000
    Axel BolteHBM PartnersInvestment Professional, Private Equity000 0000
    Gino SantiniSelfBoard Member000 0000
    James Topper Ph.DFrazier Healthcare PartnersManaging General Partner, Life Sciences000 0000
    Robert Alexander Ph.DAllena PharmaceuticalsBoard of Director000 0000
    Alexey Margolin Ph.D Co-Founder, Chief Executive Officer & Board Member Allena Pharmaceuticals
    Axel Bolte Investment Professional, Private Equity HBM Partners
    Gino Santini Board Member Self
    James Topper Ph.D Managing General Partner, Life Sciences Frazier Healthcare Partners
    Robert Alexander Ph.D Board of Director Allena Pharmaceuticals
    Request full access to PitchBook